http://www.xconomy.com/boston/2009/07/16/biogen-idec-trying-to-go-beyond-rituxan-assembles-cancer-drug-pipeline/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 03:54:18 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/boston/2009/07/16/biogen-idec-trying-to-go-beyond-rituxan-assembles-cancer-drug-pipeline/comment-page-1/#comment-71027 Research identifies successful new treatment for Hodgkin’s lymphoma - PhysOrg | The Leukemia Lymphoma Cancer Blog Thu, 16 Jul 2009 08:59:49 +0000 http://www.xconomy.com/?p=32260#comment-71027 [...] Biogen Idec, as avid biotech readers know, is the world’s largest maker of multiple sclerosis drugs . Not the world’s largest maker of cancer drugs. Not even close. Yet the Cambridge, MA-based biotech company (NASDAQ: BIIB ) has its sights on Read More [...] [...] Biogen Idec, as avid biotech readers know, is the world’s largest maker of multiple sclerosis drugs . Not the world’s largest maker of cancer drugs. Not even close. Yet the Cambridge, MA-based biotech company (NASDAQ: BIIB ) has its sights on Read More [...]

]]>